22nd Century Group (XXII) Stock Price, News & Analysis

Company Overview

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

Key Stats

• Today's Range: $2.43 to $2.59
• 50-Day Range: $2.46 to $17.43
• 52-Week Range: $2.18 to $2,328.75
• Volume: 243,977 shs
• Average Volume: 2.76 million shs
• Market Capitalization: $1.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

22nd Century Group Stock Analysis - MarketRank™

22nd Century Group scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for 22nd Century Group.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of 22nd Century Group is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of 22nd Century Group is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

22nd Century Group has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

46.11% of the float of 22nd Century Group has been sold short.

Short Interest Ratio / Days to Cover

22nd Century Group has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in 22nd Century Group has recently increased by 95.86%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

22nd Century Group does not currently pay a dividend.

Dividend Growth

22nd Century Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

46.11% of the float of 22nd Century Group has been sold short.

Short Interest Ratio / Days to Cover

22nd Century Group has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in 22nd Century Group has recently increased by 95.86%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.00

News Sentiment

22nd Century Group has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for 22nd Century Group this week, compared to 1 article on an average week.

Search Interest

9 people have searched for XXII on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.

MarketBeat Follows

5 people have added 22nd Century Group to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, 22nd Century Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.01% of the stock of 22nd Century Group is held by insiders.

Percentage Held by Institutions

Only 18.06% of the stock of 22nd Century Group is held by institutions.

XXII Stock Analysis - Frequently Asked Questions

How have XXII shares performed this year?

22nd Century Group's stock was trading at $122.13 at the beginning of 2025. Since then, XXII stock has decreased by 98.0% and is now trading at $2.48.

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc (NASDAQ:XXII) issued its quarterly earnings data on Tuesday, May, 13th. The biotechnology company reported ($43.47) earnings per share for the quarter, missing analysts' consensus estimates of ($25.30) by $18.17. The biotechnology company had revenue of $5.96 million for the quarter, compared to analyst estimates of $4.70 million. 22nd Century Group had a negative net margin of 57.62% and a negative trailing twelve-month return on equity of 524.68%.
Read the conference call transcript.

When did 22nd Century Group's stock split?

Shares of 22nd Century Group reverse split on Tuesday, December 17th 2024.The 1-135 reverse split was announced on Friday, December 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

How do I buy shares of 22nd Century Group?

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 22nd Century Group investors own include NVIDIA (NVDA), Meta Platforms (META), Canopy Growth (CGC), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), Micron Technology (MU) and Novavax (NVAX).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 8/07/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: TOBACCO
• Sub-Industry: Cannabis
• Current Symbol: NASDAQ:XXII
• Previous Symbol: AMEX:XXII
• CIK: 1347858
• Web: www.xxiicentury.com
• Phone: (716) 270-1523
• Fax: 716-877-3064
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2,986.49)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$15.16 million
• Net Margins: -57.62%
• Pretax Margin: -55.67%
• Return on Equity: -524.68%
• Return on Assets: -57.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.68
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $24.38 million
• Price / Sales: 0.05
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $53.71 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 510,000
• Free Float: 506,000
• Market Cap: $1.26 million
• Optionable: Optionable
• Beta: 1.72